#USA #Los Angeles #Parkinson's Disease #Wisner Baum #Chlorpyrifos

Wisner Baum Takes Action Against Chlorpyrifos Manufacturers

In a notable development in the world of environmental law, Wisner Baum LLP has filed a lawsuit in the Los Angeles County Superior Court against two major pesticide manufacturers, The Dow Chemical Company and Corteva. The lawsuit claims that the use of chlorpyrifos, an organophosphate insecticide, is linked to serious health issues, specifically early-onset Parkinson's disease.

The case arises from the experiences of a client from Los Angeles County who attributes his diagnosis of Parkinson's to prolonged exposure to chlorpyrifos fumes, which were allegedly released by nearby commercial nurseries applying the pesticide. This legal action seeks to address the claims that these corporations neglected to adequately study and disclose the potential neurological risks associated with their products.

The Background of the Lawsuit

Chlorpyrifos, developed by Dow in the 1950s, became a staple in agricultural pest control due to its effectiveness. However, as research evolved, so did concerns regarding its safety, particularly for residential environments. The lawsuit by Wisner Baum alleges that both Dow and Corteva have not only failed to provide a thorough examination of the long-term effects of chlorpyrifos on humans but have also disregarded the necessity to inform the public about the dangers associated with its use.

According to the complaint, the plaintiff lived adjacent to commercial nurseries that utilized chlorpyrifos from 2003 to 2020. This proximity, without any effective barriers, allegedly exposed him to pesticide drift directly impacting his health.

Allegations of Negligence

Sasha Shariati, an attorney representing the plaintiff, pointed out, "Chlorpyrifos manufacturers had decades to study what this chemical does to the human nervous system. This lawsuit seeks to hold them accountable for what they knew and what they chose not to tell the public."

The complaint emphasizes that the defendants failed to communicate the risks of chlorpyrifos through various means that extended beyond the limited information found on EPA-approved product labels. Evidence cited in the lawsuit suggests that adequate safety measures and warnings were not provided, placing nearby residents at additional risk. The nurseries also allegedly neglected to implement reasonable measures to prevent spray drift, which could have minimized exposure for those living nearby.

Scientific Evidence and Claims

The lawsuit is underpinned by scientific research that is believed to document a correlation between chlorpyrifos exposure and the onset of Parkinson's disease. Notably, California has taken significant steps in addressing concerns regarding chlorpyrifos, ultimately aiming to prohibit nearly all sales and usage of the pesticide by 2020.

It is important to highlight that the lawsuit contains claims of negligent failure to warn and design defect, alongside trespassing accusations against the nurseries. The complainants are seeking both compensatory and punitive damages for the alleged harm caused by the manufacturers' and nurseries' actions.

Regulatory Context and Future Actions

The ongoing ramifications of this case resonate beyond the courtroom, as the use of chlorpyrifos has been increasingly scrutinized, particularly within a global context. The European Union has also acted to withdraw its approval for chlorpyrifos, with a global elimination mandate scheduled to take effect by the end of 2026.

Wisner Baum has established a reputation for advocating on behalf of individuals who have suffered from exposure to harmful chemicals. The firm has previously engaged in prominent litigation against chemical manufacturers, further enhancing its commitment to holding corporations accountable for their actions.

As this lawsuit unfolds, the implications of chlorpyrifos on public health will continue to spark conversations regarding pesticide safety, regulatory practices, and environmental justice. Wisner Baum is currently reviewing additional claims related to chlorpyrifos exposure and its health effects, emphasizing the importance of community awareness and legal recourse in mitigating the dangers posed by hazardous substances.